Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Clinical trial NCT06176690 · RECRUITING

Trial details

NCT number: NCT06176690
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CD30-Positive Diffuse Large B-Cell Lymphoma Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type Anaplastic Large Cell Lymphoma, ALK-Positive Peripheral T-cell Lymphoma Anaplastic Large Cell Lymphoma, ALK-negative Non-Hodgkin Lymphoma Hodgkin Lymphoma

Start date: 2025-10-27
Primary completion: 2028-07-27
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.